Management of Persons Exposed to Multidrug-resistant Tuberculosis

Overview

Journal MMWR Recomm Rep

Specialty Public Health

Date 1992 Jun 19

PMID 1640921

Citations 20

Affiliations

Soon will be listed here.

Abstract

Recent outbreaks of multidrug-resistant tuberculosis (MDR-TB) have posed challenges for the management of exposed persons. This report offers suggestions for evaluating and managing persons (i.e., contacts) who have been exposed to patients with infectious MDR-TB (TB due to strains of Mycobacterium tuberculosis resistant to both isoniazid [INH] and rifampin [RIF]), provides background information on alternative preventive therapy regimens with drugs other than INH or RIF, and presents considerations relevant to making a decision to offer one of these alternative regimens.

Citing Articles

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Nahid P, Mase S, Migliori G, Sotgiu G, Bothamley G, Brozek J Am J Respir Crit Care Med. 2019; 200(10):e93-e142.

PMID: 31729908 PMC: 6857485. DOI: 10.1164/rccm.201909-1874ST.

How to manage children who have come into contact with patients affected by tuberculosis.

Lancella L, Lo Vecchio A, Chiappini E, Tadolini M, Cirillo D, Tortoli E J Clin Tuberc Other Mycobact Dis. 2019; 1:1-12.

PMID: 31723675 PMC: 6850253. DOI: 10.1016/j.jctube.2015.07.002.

Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP).

Seddon J, Garcia-Prats A, Purchase S, Osman M, Demers A, Hoddinott G Trials. 2018; 19(1):693.

PMID: 30572905 PMC: 6302301. DOI: 10.1186/s13063-018-3070-0.

Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).

Swindells S, Gupta A, Kim S, Hughes M, Sanchez J, Mave V Int J Tuberc Lung Dis. 2018; 22(9):1016-1022.

PMID: 30092866 PMC: 6104641. DOI: 10.5588/ijtld.18.0163.

Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis.

Seddon J, Schaaf H Pneumonia (Nathan). 2017; 8:20.

PMID: 28702299 PMC: 5471710. DOI: 10.1186/s41479-016-0019-5.